Calamos Advisors »

Ptc Therapeutics shares owned by Calamos Advisors

Quarter-by-quarter ownership of Ptc Therapeutics shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Ptc Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $49k 33k 1.48

More positions owned by Calamos Advisors

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Western Digital Corp Note 3.000%11/1 (Principal)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Calamos Advisors

Top funds holding Ptc Therapeutics

Franklin Resources
Tenor Capital Management
Capstone Investment Advisors
OZ Management
D. E. Shaw & Co
Linden Advisors
DeepCurrents Investment Group
Whitebox Advisors
Lazard Asset Management
CSS
SSI Investment Management
BlackRock
Kornitzer Capital Management
Central Pacific Bank - Trust Division
Calamos Advisors

View all funds holding Ptc Therapeutics